Discover Tenders by Antiretroviral Drugs Sector

Find the most relevant tenders for Antiretroviral Drugs. Access the latest tender notices from various government and private organizations published across hundreds of websites and newspapers.Obtain complete and accurate information on Antiretroviral Drugs tenders, including all tender documents, RFPs, RFQs,and more. Utilize our advanced filters to search for Antiretroviral Drugs tenders by organization, tender value, opening and closing dates, and more.

Filter Your Search

Country

Sector

Region

Funding Agency

Contract Announcement Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V For Drugs With The Active Ingredient Follitropin Alfa Bemfola

Deadline: 10 Feb 2026

Germany

Ref. No.: 4070882

EMD:Ref Document

Bid Value: Ref Document

290 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicines With The Active Ingredient Haloperidol N05Ad01 As Part Of A So Called Open House Model

Deadline: 31 Jan 2026

Germany

Ref. No.: 3999046

EMD:Ref Document

Bid Value: Ref Document

280 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicines With The Active Ingredient Mesalazine A07Ec02 As Part Of A So Called Open House Model

Deadline: 31 Jan 2026

Germany

Ref. No.: 3998161

EMD:Ref Document

Bid Value: Ref Document

280 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Drugs With The Active Ingredient Testosterone G03Ba03 As Part Of A So Called Open House Model

Deadline: 31 Jan 2026

Germany

Ref. No.: 3997903

EMD:Ref Document

Bid Value: Ref Document

280 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicines With The Active Ingredient Carbamazepine N03Af01 As Part Of A So Called Open House Model

Deadline: 31 Jan 2026

Germany

Ref. No.: 3995591

EMD:Ref Document

Bid Value: Ref Document

280 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Drugs With The Active Ingredient Palonosetron A04Aa05 As Part Of A So Called Open House Model

Deadline: 31 Jan 2026

Germany

Ref. No.: 3992888

EMD:Ref Document

Bid Value: Ref Document

280 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Drugs With The Active Ingredient Adalimumab L04Ab04 As Part Of A So Called Open House Model

Deadline: 31 Jan 2026

Germany

Ref. No.: 3940896

EMD:Ref Document

Bid Value: Ref Document

280 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Drugs With The Active Ingredient Infliximab L04Ab02 As Part Of A So Called Open House Model

Deadline: 31 Jan 2026

Germany

Ref. No.: 3940617

EMD:Ref Document

Bid Value: Ref Document

280 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Drugs With The Active Ingredient Etanercept L04Ab01 As Part Of A So Called Open House Model

Deadline: 31 Jan 2026

Germany

Ref. No.: 3934657

EMD:Ref Document

Bid Value: Ref Document

280 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For Drugs With The Active Ingredient Combination Of Tafluprost And Timolol Atc Code S01Ed70

Deadline: 25 Jan 2026

Germany

Ref. No.: 3891624

EMD:Ref Document

Bid Value: Ref Document

274 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For Drugs With The Active Ingredient Combination Of Oxycodone And Naloxone Atc Code N02Aa55

Deadline: 25 Jan 2026

Germany

Ref. No.: 3882987

EMD:Ref Document

Bid Value: Ref Document

274 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For Medicines With The Active Ingredient Ciclosporin Atc Code S01Xa18

Deadline: 25 Jan 2026

Germany

Ref. No.: 3882975

EMD:Ref Document

Bid Value: Ref Document

274 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Dexamethasone Exclusively Imp Atc S01Ba01 For The Period April 1St 2024 March 31St 2026

Deadline: 05 Feb 2026

Germany

Ref. No.: 3882718

EMD:Ref Document

Bid Value: Ref Document

285 Days Left

Open House Drug Discount Agreements Rivaroxaban With A Potency Of 2 5 Mg Film Coated Tablets And Hard Capsules Atc B01Af01

Deadline: 05 Feb 2026

Germany

Ref. No.: 3882690

EMD:Ref Document

Bid Value: Ref Document

285 Days Left

Open House Drug Discount Agreements Rivaroxaban Film Coated Tablets Except With A Strength Of 2 5 Mg Atc B01Af01

Deadline: 05 Feb 2026

Germany

Ref. No.: 3882382

EMD:Ref Document

Bid Value: Ref Document

285 Days Left

Showing 38836 to 38850 of 38887 results

‹
1
2
...
2584
2585
2586
2587
2588
2589
2590
2591
2592
2593
›

Discover Tenders by Antiretroviral Drugs Sector

Filter Your Search

Tenders by Countries

Browse Popular Sectors

Projects by Regions

Funding Agency

Support

CONTACT DETAILS

Discover Tenders by Antiretroviral Drugs Sector

Filter Your Search

FREE Trial plan for all new users!